Brinzolamide/Timolol STADA

Medicinal product

(Invented) name

Brinzolamide/Timolol STADA

Active substance (s)

Brinzolamidas/Timololis

Strength

10 mg/5 mg/ml

Pharmaceutical form

akių lašai (suspensija)

Route (s) of administration

vartoti ant akių

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

S01ED51, Timolol, combinations

Marketing authorisation holder

STADA Arzneimittel AG, Vokietija

Date of authorisation

2021-10-22

Date of renewal

2024-05-21

Documents

4840 pakuotes lapelis_2024-05-21.docx

4840 Brinz_Timol_STADA_perr2024-05-21.docx

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(3)

Procedure number

SE/H/1764/001/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

1 ml suspensijos yra:	1 ml
Brinzolamidas	10 mg
Timololis	5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
107460	93565	1093565	buteliukas	5 ml N1		Receptinis	LT/1/21/4840/001	Netiekiama	-	-	No	-	-	Download
107461	93566	1093566	buteliukas	5 ml N3		Receptinis	LT/1/21/4840/002	Netiekiama	-	-	No	-	-
107462	93567	1093567	buteliukas	5 ml N6		Receptinis	LT/1/21/4840/003	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2025-06-30	Išregistruotas
2024-05-21	Perregistruotas
2021-10-22	Registruotas